Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway
Abstract Background Effective-component compatibility of Bufei Yishen formula III (ECC-BYF III) demonstrates positive effects on stable chronic obstructive pulmonary disease (COPD). Purpose To investigate the mechanisms of ECC-BYF III on COPD rats from the aspect of airway epithelial cell senescence...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2022-11-01
|
| Series: | BMC Pulmonary Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12890-022-02191-9 |
| _version_ | 1811211018979770368 |
|---|---|
| author | Min-yan Li Yan-qin Qin Yan-ge Tian Kang-chen Li Brian G. Oliver Xue-fang Liu Peng Zhao Jian-sheng Li |
| author_facet | Min-yan Li Yan-qin Qin Yan-ge Tian Kang-chen Li Brian G. Oliver Xue-fang Liu Peng Zhao Jian-sheng Li |
| author_sort | Min-yan Li |
| collection | DOAJ |
| description | Abstract Background Effective-component compatibility of Bufei Yishen formula III (ECC-BYF III) demonstrates positive effects on stable chronic obstructive pulmonary disease (COPD). Purpose To investigate the mechanisms of ECC-BYF III on COPD rats from the aspect of airway epithelial cell senescence. Methods COPD model rats (Sprague-Dawley rat) were treated with ECC-BYF III for 8 weeks, and the efficacy was evaluated. Cigarette smoke extract (CSE)-induced senescence model of airway epithelial cells was treated with ECC-BYF III, and related enzymes and proteins involved in oxidative stress and mitophagy were detected. Results ECC-BYF III markedly rescued pulmonary function and histopathological changes, which might be associated with the amelioration of lung senescence, including the reduction of malondialdehyde (MDA) and tumor necrosis factor-α (TNF-α), interleukin (IL)-6 and matrix metalloproteinase (MMP)-9 levels, increase of the level in total superoxide dismutase (T-SOD), and decease in the p21 level in the airways. Furthermore, ECC-BYF III suppressed p16 and p21 expressions and senescence-associated β-galactosidase (SA-β-Gal) in CSE-induced airway epithelial cells. Moreover, ECC-BYF III upregulated mitophagy-related proteins, including the co-localizations of TOM20 and LC3B, PINK1 and PARK2, and improved mitochondrial function by upregulating mitochondrial mitofusin (MFN)2 and reducing dynamin-related protein 1 (DRP1) expression. ECC-BYF III enhanced the activities of T-SOD and GSH-PX by up-regulating NRF2, thus inhibiting oxidative stress. After intervention with NRF2 inhibitor, the regulation effects of ECC-BYF III on oxidative stress, mitophagy and senescence in airway epithelial cells were significantly suppressed. Conclusions ECC-BYF III exerts beneficial effects on COPD rats by ameliorating airway epithelial cell senescence, which is mediated by inhibiting oxidative stress and subsequently enhancing mitophagy through the activation of NRF2 signaling. |
| first_indexed | 2024-04-12T05:05:55Z |
| format | Article |
| id | doaj.art-47e116dc27f64e1c9aa499c27b8b525d |
| institution | Directory Open Access Journal |
| issn | 1471-2466 |
| language | English |
| last_indexed | 2024-04-12T05:05:55Z |
| publishDate | 2022-11-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Pulmonary Medicine |
| spelling | doaj.art-47e116dc27f64e1c9aa499c27b8b525d2022-12-22T03:46:53ZengBMCBMC Pulmonary Medicine1471-24662022-11-0122111210.1186/s12890-022-02191-9Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathwayMin-yan Li0Yan-qin Qin1Yan-ge Tian2Kang-chen Li3Brian G. Oliver4Xue-fang Liu5Peng Zhao6Jian-sheng Li7Henan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese MedicineHenan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese MedicineHenan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese MedicineHenan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese MedicineHenan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese MedicineHenan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese MedicineHenan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese MedicineHenan Key Laboratory of Chinese Medicine for Respiratory Disease, Henan University of Chinese MedicineAbstract Background Effective-component compatibility of Bufei Yishen formula III (ECC-BYF III) demonstrates positive effects on stable chronic obstructive pulmonary disease (COPD). Purpose To investigate the mechanisms of ECC-BYF III on COPD rats from the aspect of airway epithelial cell senescence. Methods COPD model rats (Sprague-Dawley rat) were treated with ECC-BYF III for 8 weeks, and the efficacy was evaluated. Cigarette smoke extract (CSE)-induced senescence model of airway epithelial cells was treated with ECC-BYF III, and related enzymes and proteins involved in oxidative stress and mitophagy were detected. Results ECC-BYF III markedly rescued pulmonary function and histopathological changes, which might be associated with the amelioration of lung senescence, including the reduction of malondialdehyde (MDA) and tumor necrosis factor-α (TNF-α), interleukin (IL)-6 and matrix metalloproteinase (MMP)-9 levels, increase of the level in total superoxide dismutase (T-SOD), and decease in the p21 level in the airways. Furthermore, ECC-BYF III suppressed p16 and p21 expressions and senescence-associated β-galactosidase (SA-β-Gal) in CSE-induced airway epithelial cells. Moreover, ECC-BYF III upregulated mitophagy-related proteins, including the co-localizations of TOM20 and LC3B, PINK1 and PARK2, and improved mitochondrial function by upregulating mitochondrial mitofusin (MFN)2 and reducing dynamin-related protein 1 (DRP1) expression. ECC-BYF III enhanced the activities of T-SOD and GSH-PX by up-regulating NRF2, thus inhibiting oxidative stress. After intervention with NRF2 inhibitor, the regulation effects of ECC-BYF III on oxidative stress, mitophagy and senescence in airway epithelial cells were significantly suppressed. Conclusions ECC-BYF III exerts beneficial effects on COPD rats by ameliorating airway epithelial cell senescence, which is mediated by inhibiting oxidative stress and subsequently enhancing mitophagy through the activation of NRF2 signaling.https://doi.org/10.1186/s12890-022-02191-9Chronic obstructive pulmonary diseaseEffective-component compatibility of Bufei Yishen formula IIIAirway epithelial cell senescenceOxidative stressMitophagy |
| spellingShingle | Min-yan Li Yan-qin Qin Yan-ge Tian Kang-chen Li Brian G. Oliver Xue-fang Liu Peng Zhao Jian-sheng Li Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway BMC Pulmonary Medicine Chronic obstructive pulmonary disease Effective-component compatibility of Bufei Yishen formula III Airway epithelial cell senescence Oxidative stress Mitophagy |
| title | Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway |
| title_full | Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway |
| title_fullStr | Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway |
| title_full_unstemmed | Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway |
| title_short | Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway |
| title_sort | effective component compatibility of bufei yishen formula iii ameliorated copd by improving airway epithelial cell senescence by promoting mitophagy via the nrf2 pink1 pathway |
| topic | Chronic obstructive pulmonary disease Effective-component compatibility of Bufei Yishen formula III Airway epithelial cell senescence Oxidative stress Mitophagy |
| url | https://doi.org/10.1186/s12890-022-02191-9 |
| work_keys_str_mv | AT minyanli effectivecomponentcompatibilityofbufeiyishenformulaiiiamelioratedcopdbyimprovingairwayepithelialcellsenescencebypromotingmitophagyviathenrf2pink1pathway AT yanqinqin effectivecomponentcompatibilityofbufeiyishenformulaiiiamelioratedcopdbyimprovingairwayepithelialcellsenescencebypromotingmitophagyviathenrf2pink1pathway AT yangetian effectivecomponentcompatibilityofbufeiyishenformulaiiiamelioratedcopdbyimprovingairwayepithelialcellsenescencebypromotingmitophagyviathenrf2pink1pathway AT kangchenli effectivecomponentcompatibilityofbufeiyishenformulaiiiamelioratedcopdbyimprovingairwayepithelialcellsenescencebypromotingmitophagyviathenrf2pink1pathway AT briangoliver effectivecomponentcompatibilityofbufeiyishenformulaiiiamelioratedcopdbyimprovingairwayepithelialcellsenescencebypromotingmitophagyviathenrf2pink1pathway AT xuefangliu effectivecomponentcompatibilityofbufeiyishenformulaiiiamelioratedcopdbyimprovingairwayepithelialcellsenescencebypromotingmitophagyviathenrf2pink1pathway AT pengzhao effectivecomponentcompatibilityofbufeiyishenformulaiiiamelioratedcopdbyimprovingairwayepithelialcellsenescencebypromotingmitophagyviathenrf2pink1pathway AT jianshengli effectivecomponentcompatibilityofbufeiyishenformulaiiiamelioratedcopdbyimprovingairwayepithelialcellsenescencebypromotingmitophagyviathenrf2pink1pathway |